Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Cash from Operations: 2009-2025

Historic Cash from Operations for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $287.6 million.

  • BIO-TECHNE's Cash from Operations fell 56.82% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.3 million, marking a year-over-year decrease of 17.21%. This contributed to the annual value of $287.6 million for FY2025, which is 3.82% down from last year.
  • As of FY2025, BIO-TECHNE's Cash from Operations stood at $287.6 million, which was down 3.82% from $299.0 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Cash from Operations ranged from a high of $352.2 million in FY2021 and a low of $254.4 million during FY2023.
  • Moreover, its 3-year median value for Cash from Operations was $287.6 million (2025), whereas its average is $280.3 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first spiked by 71.61% in 2021, then fell by 21.79% in 2023.
  • Yearly analysis of 5 years shows BIO-TECHNE's Cash from Operations stood at $352.2 million in 2021, then fell by 7.64% to $325.3 million in 2022, then declined by 21.79% to $254.4 million in 2023, then grew by 17.53% to $299.0 million in 2024, then dropped by 3.82% to $287.6 million in 2025.